DLA Piper
We only have limited information for this firm. Consider the following firms which have provided more information:
DLA Piper’s healthcare and life sciences practice spans the sector, with experience in corporate, regulatory, public procurement, privacy, IP, competition and litigation. The firm advises major players in the industry, including national and multinational pharmaceutical corporations, on domestic and cross-border matters. Roberto Valenti is the head of the department at the firm; he advises on IP litigation and commercial matters in the life science sectors, with particular expertise on matters involving medical devices. Marco de Morpurgo focuses on the EU and national regulation of pharmaceuticals, biotech and medical devices. Raffaella Quintana (compliance and criminal law) and Gualtiero Dragotti (IP) can bring their considerable talents to this sector.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team is well prepared, open and available to specific requests. They are also skilled at managing discussions and talented. ’
‘Empathetic and personalized customer management.’
Abbreviated data is displayed for this firm.
Key clients
- Pfizer Inc.
- GlaxoSmithKline
Abbreviated data is displayed for this firm.
Work highlights
- Advised Pfizer Inc. with regard to the agreement for the supply of their Covid-19 Vaccine across Europe.
- Assisting Medtronic Inc. in a patent dispute among European leading manufacturers and suppliers of a range of medical devices for respiratory support, in connection with the alleged infringement of two European patents referred to devices for oxygen administration in the intensive therapy.
Abbreviated data is displayed for this firm.